Comment: Recommended for medical law, this specialist boutique has already managed to build up an extensive, first-class and broad client base a good year after opening its doors. It is clear to see here that the team, made up of four Clifford Chance lawyers and a lawyer who came from an association, is well-connected in the market and that the individual members perfectly complement one another’s strengths. One client praised the “quality” and the “super team” supporting Stallberg and Heil. Competitors approvingly highlight the strong Brussels contacts of one partner, who is also the managing director of the EUCOPE association. These contacts give the firm a more international setup than other boutiques. Strategically, with its profound regulatory expertise in transactions, it lends itself well as a partner to US firms lacking the relevant industry-specific know-how and is therefore already extremely successful here. The firm is assisting in several transactions for clients which it then often subsequently advises on contract drafting. One client enthusiastically remarked on the advice received in a deal in the outpatient sector. Stallberg enjoys an excellent reputation in the market for his expert advice on market entry and reimbursement of costs. In terms of personnel, this partner-centric entity took the next logical step and expanded at associate level besides also hiring a new graduate.
Recommended: Dr. Christian Stallberg (“great approach to things”, “really strong in regulatory”, competitors), Maria Heil (“knows her stuff”, competitor).
Practice: Comprehensive advice to the industry focused on sector-specific contract drafting and regulatory transaction advice (also cross-border) as well as reimbursement of costs and market access. Also pharma advertising, compliance and product liability. Data protection/e-health. Clients: pharma companies, medical product manufacturers, biotech companies, associations. Also hospitals, care homes, medical centers and financial investors. (5 partners, 1 associate)
Clients: ?? Dr. Kade on purchase of herbal medicinal product from Hexal and on supply agreement; all-round advice to Bayer on AMNOG; ongoing advice to Janssen-Cilag on AMNOG; ongoing advice to Takeda on pharma advertising, regulatory, compliance, data protection and contracts; all-round advice to Jenapharm on social law.
  • Teilen